133 related articles for article (PubMed ID: 28123887)
1. CD4
Morandi F; Pozzi S; Barco S; Cangemi G; Amoroso L; Carlini B; Pistoia V; Corrias MV
Oncoimmunology; 2016; 5(12):e1249553. PubMed ID: 28123887
[TBL] [Abstract][Full Text] [Related]
2. Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.
Zhao XY; Wang YT; Mo XD; Zhao XS; Wang YZ; Chang YJ; Huang XJ
J Transl Med; 2015 May; 13():145. PubMed ID: 25948100
[TBL] [Abstract][Full Text] [Related]
3. IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome.
Morandi F; Croce M; Cangemi G; Barco S; Rigo V; Carlini B; Amoroso L; Pistoia V; Ferrini S; Corrias MV
J Immunol Res; 2015; 2015():718975. PubMed ID: 25961062
[TBL] [Abstract][Full Text] [Related]
4. FoxP3
Meng H; Zheng S; Zhou Q; Gao Y; Ni Y; Liang H; Chen S
Front Neurol; 2021; 12():755356. PubMed ID: 34975721
[No Abstract] [Full Text] [Related]
5. Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells.
Chevalier MF; Didier C; Petitjean G; Karmochkine M; Girard PM; Barré-Sinoussi F; Scott-Algara D; Weiss L
J Infect Dis; 2015 Mar; 211(5):769-79. PubMed ID: 25281758
[TBL] [Abstract][Full Text] [Related]
6. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the frequencies and functions of CD4
Zare M; Namavar Jahromi B; Gharesi-Fard B
J Reprod Immunol; 2019 Jun; 133():43-51. PubMed ID: 31255887
[TBL] [Abstract][Full Text] [Related]
8. Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.
Shenghui Z; Yixiang H; Jianbo W; Kang Y; Laixi B; Yan Z; Xi X
Int J Cancer; 2011 Sep; 129(6):1373-81. PubMed ID: 21105040
[TBL] [Abstract][Full Text] [Related]
9. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression].
Chen YL; Chen XR; Qin LX; Yang YF; Tang YM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412
[TBL] [Abstract][Full Text] [Related]
10. Peripheral Tr1 and Foxp3
Ikemoto T; Shimada M; Ishikawa D; Kawashita Y; Teraoku H; Yoshikawa M; Yamada S; Saito YU; Morine Y; Imura S
Anticancer Res; 2017 Oct; 37(10):5541-5552. PubMed ID: 28982868
[TBL] [Abstract][Full Text] [Related]
11. Decreased proportions of CD4 + IL17+/CD4 + CD25 + CD127- and CD4 + IL17+/CD4 + CD25 + CD127 - FoxP3+ T cells in children with autoimmune thyroid diseases (.).
Bossowski A; Moniuszko M; Idźkowska E; Grubczak K; Singh P; Bossowska A; Diana T; Kahaly GJ
Autoimmunity; 2016 Aug; 49(5):320-8. PubMed ID: 27206624
[TBL] [Abstract][Full Text] [Related]
12. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
13. Functional heterogeneity of circulating T regulatory cell subsets in breast cancer patients.
Ostapchuk YO; Perfilyeva YV; Kustova EA; Urazalieva NT; Omarbaeva NA; Talaeva SG; Belyaev NN
Breast Cancer; 2018 Nov; 25(6):687-697. PubMed ID: 29797233
[TBL] [Abstract][Full Text] [Related]
14. CD4
Niedźwiecki M; Budziło O; Zieliński M; Adamkiewicz-Drożyńska E; Maciejka-Kembłowska L; Szczepański T; Trzonkowski P
J Immunol Res; 2018; 2018():1292404. PubMed ID: 30003111
[TBL] [Abstract][Full Text] [Related]
15. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
16. Effects of estrogen on CD4(+) CD25(+) regulatory T cell in peripheral blood during pregnancy.
Xiong YH; Yuan Z; He L
Asian Pac J Trop Med; 2013 Sep; 6(9):748-52. PubMed ID: 23827156
[TBL] [Abstract][Full Text] [Related]
17. Minimal residual disease in high-risk neuroblastoma shows a dynamic and disease burden-dependent correlation between bone marrow and peripheral blood.
Lin KS; Uemura S; Thwin KKM; Nakatani N; Ishida T; Yamamoto N; Tamura A; Saito A; Mori T; Hasegawa D; Kosaka Y; Nino N; Nagano C; Takafuji S; Iijima K; Nishimura N
Transl Oncol; 2021 Aug; 14(8):101019. PubMed ID: 33993097
[TBL] [Abstract][Full Text] [Related]
18. TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.
Yáñez Y; Hervás D; Grau E; Oltra S; Pérez G; Palanca S; Bermúdez M; Márquez C; Cañete A; Castel V
J Cancer Res Clin Oncol; 2016 Mar; 142(3):573-80. PubMed ID: 26498952
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].
Zhang HH; Guo F; Fei R; Ma H; Cong X; Wei L; Chen HS
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):511-5. PubMed ID: 18649763
[TBL] [Abstract][Full Text] [Related]
20. Distinct Expression Profiles of Neuroblastoma-Associated mRNAs in Peripheral Blood and Bone Marrow of Non-High-Risk and High-Risk Neuroblastoma Patients.
Nakatani N; Win KHN; Mon CY; Fujikawa T; Uemura S; Saito A; Ishida T; Mori T; Hasegawa D; Kosaka Y; Inoue S; Nishimura A; Nino N; Tamura A; Yamamoto N; Nozu K; Nishimura N
Biology (Basel); 2024 May; 13(5):. PubMed ID: 38785826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
